New patent expiration for Bristol-myers drug ABRAXANE
Drug Patent Watch
JUNE 8, 2024
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Bristol-myers and is included in one NDA. It is available from three suppliers.
Drug Patent Watch
JUNE 8, 2024
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Bristol-myers and is included in one NDA. It is available from three suppliers.
ECRG Media's Clinical Research Podcast
JUNE 8, 2024
What makes a great CRA monitoring room? Send in a voice message: [link] What makes a great CRA monitoring room?
Drug Patent Watch
JUNE 8, 2024
This chart shows the patent expirations for solution dosed drugs over the next decade. The term of drug patents varies.
Let's personalize your content